MARYAM ZAREI: Open Payments
NPI 1982649505 · POWAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 50 payments from 19 companies in 2025. Trend: 2023 $1,878 · 2024 $1,888 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $190 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| GlaxoSmithKline, LLC. | 6 | $129 |
| CSL Behring | 1 | $125 |
| Blueprint Medicines Corporation | 2 | $71 |
| PFIZER INC. | 3 | $61 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $52 |
| BioCryst US Sales Co., LLC | 2 | $51 |
| Amgen Inc. | 2 | $47 |
| Incyte Corporation | 2 | $42 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Hizentra, BREZTRI, AYVAKIT, TEZSPIRE, NEFFY, ORLADEYO.
Industry payments across CA — which companies pay providers there.
